GENE ONLINE|News &
Scientists Jointly Urge FDA to Evaluate T-Cell Response in Review of COVID-19 Vaccines
More than 60 scientists have signed a letter to the U.S. Food and Drug Administration (FDA), requesting that in addition to measuring antibodies after vaccination, the agency should also focus on measuring T-cell responses to help make more accurate, long-term assessments of vaccine effectiveness and to make effective preventive decisions before new mutations of SARS-CoV-2 occur.
It's free! Log in now to read
LATEST
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
